News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
03 17 2011 Test designed to promote colorectal cancer evaluation of the nearly 53 million patients in the U.S. who resist recommended screeningQuest Diagnostics Incorporated (NYSE: DGX), the world's leading cancer diagnostics company, today announced that its ColoVantage test has been...
-
03 14 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
-
03 04 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it has...
-
02 28 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
-
02 24 2011 -- Addition of Premier Provider of Neurology Testing to Complement Quest Diagnostics' Leadership in Testing for Cancer, Infectious Disease and Cardiovascular Disease --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has...